世界の治療用血漿交換市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04839)
◆英語タイトル:Global Therapeutic Plasma Exchange Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04839
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:90
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは治療用血漿交換の世界市場について調査・分析した資料です。種類別(神経障害、腎障害、血液疾患、代謝障害、その他)の市場規模、用途別(病院、専門クリニック、外来外科センター)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別治療用血漿交換の競争状況、市場シェア
・世界の治療用血漿交換市場:種類別市場規模 2015年-2020年(神経障害、腎障害、血液疾患、代謝障害、その他)
・世界の治療用血漿交換市場:種類別市場規模予測 2021年-2026年(神経障害、腎障害、血液疾患、代謝障害、その他)
・世界の治療用血漿交換市場:用途別市場規模 2015年-2020年(病院、専門クリニック、外来外科センター)
・世界の治療用血漿交換市場:用途別市場規模予測 2021年-2026年(病院、専門クリニック、外来外科センター)
・北米の治療用血漿交換市場分析:米国、カナダ
・ヨーロッパの治療用血漿交換市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの治療用血漿交換市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の治療用血漿交換市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの治療用血漿交換市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Asahi Kasei Corporation、Baxter International、Terumo Corporation、B. Braun、Fresenius Kabi、Kawasumi Laboratories、Haemonetics Corporation、Cerus Corporation、Hemacare Corporation、Medica S.p.A.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely performed in the treatment of various chronic diseases as first line or as second line of therapy or as a supportive treatment.
Therapeutic plasma exchange (TPE) has wide applications in the treatment of neurological, renal, hematological, and metabolic disorders. The indications for using therapeutic plasma exchange procedures as a line of treatment are regulated through guidelines provided by the American Society for Apheresis (ASFA). It categorizes the indications in four parts: category I to IV. Category I and II depict TPE as first or second line of treatment for many neurological, renal, and hematological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura (TTP).

Market Analysis and Insights: Global Therapeutic Plasma Exchange Market
The global Therapeutic Plasma Exchange market size is projected to reach US$ 191.2 million by 2026, from US$ 173.7 million in 2020, at a CAGR of 9.3%% during 2021-2026.

Global Therapeutic Plasma Exchange Scope and Market Size
Therapeutic Plasma Exchange market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Plasma Exchange market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Asahi Kasei Corporation
Baxter International
Terumo Corporation
B. Braun
Fresenius Kabi
Kawasumi Laboratories
Haemonetics Corporation
Cerus Corporation
Hemacare Corporation
Medica S.p.A.

Market segment by Type, the product can be split into
Neurological Disorders
Renal Disorders
Hematology Disorders
Metabolic Disorders
Others
Market segment by Application, split into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Therapeutic Plasma Exchange Revenue
1.4 Market by Type
1.4.1 Global Therapeutic Plasma Exchange Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Neurological Disorders
1.4.3 Renal Disorders
1.4.4 Hematology Disorders
1.4.5 Metabolic Disorders
1.4.6 Others
1.5 Market by Application
1.5.1 Global Therapeutic Plasma Exchange Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Therapeutic Plasma Exchange Market Perspective (2015-2026)
2.2 Global Therapeutic Plasma Exchange Growth Trends by Regions
2.2.1 Therapeutic Plasma Exchange Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Therapeutic Plasma Exchange Historic Market Share by Regions (2015-2020)
2.2.3 Therapeutic Plasma Exchange Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Therapeutic Plasma Exchange Market Growth Strategy
2.3.6 Primary Interviews with Key Therapeutic Plasma Exchange Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Plasma Exchange Players by Market Size
3.1.1 Global Top Therapeutic Plasma Exchange Players by Revenue (2015-2020)
3.1.2 Global Therapeutic Plasma Exchange Revenue Market Share by Players (2015-2020)
3.1.3 Global Therapeutic Plasma Exchange Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Therapeutic Plasma Exchange Market Concentration Ratio
3.2.1 Global Therapeutic Plasma Exchange Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Therapeutic Plasma Exchange Revenue in 2019
3.3 Therapeutic Plasma Exchange Key Players Head office and Area Served
3.4 Key Players Therapeutic Plasma Exchange Product Solution and Service
3.5 Date of Enter into Therapeutic Plasma Exchange Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Therapeutic Plasma Exchange Historic Market Size by Type (2015-2020)
4.2 Global Therapeutic Plasma Exchange Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Therapeutic Plasma Exchange Market Size by Application (2015-2020)
5.2 Global Therapeutic Plasma Exchange Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Therapeutic Plasma Exchange Market Size (2015-2020)
6.2 Therapeutic Plasma Exchange Key Players in North America (2019-2020)
6.3 North America Therapeutic Plasma Exchange Market Size by Type (2015-2020)
6.4 North America Therapeutic Plasma Exchange Market Size by Application (2015-2020)

7 Europe
7.1 Europe Therapeutic Plasma Exchange Market Size (2015-2020)
7.2 Therapeutic Plasma Exchange Key Players in Europe (2019-2020)
7.3 Europe Therapeutic Plasma Exchange Market Size by Type (2015-2020)
7.4 Europe Therapeutic Plasma Exchange Market Size by Application (2015-2020)

8 China
8.1 China Therapeutic Plasma Exchange Market Size (2015-2020)
8.2 Therapeutic Plasma Exchange Key Players in China (2019-2020)
8.3 China Therapeutic Plasma Exchange Market Size by Type (2015-2020)
8.4 China Therapeutic Plasma Exchange Market Size by Application (2015-2020)

9 Japan
9.1 Japan Therapeutic Plasma Exchange Market Size (2015-2020)
9.2 Therapeutic Plasma Exchange Key Players in Japan (2019-2020)
9.3 Japan Therapeutic Plasma Exchange Market Size by Type (2015-2020)
9.4 Japan Therapeutic Plasma Exchange Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Therapeutic Plasma Exchange Market Size (2015-2020)
10.2 Therapeutic Plasma Exchange Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Therapeutic Plasma Exchange Market Size by Type (2015-2020)
10.4 Southeast Asia Therapeutic Plasma Exchange Market Size by Application (2015-2020)

11 India
11.1 India Therapeutic Plasma Exchange Market Size (2015-2020)
11.2 Therapeutic Plasma Exchange Key Players in India (2019-2020)
11.3 India Therapeutic Plasma Exchange Market Size by Type (2015-2020)
11.4 India Therapeutic Plasma Exchange Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Therapeutic Plasma Exchange Market Size (2015-2020)
12.2 Therapeutic Plasma Exchange Key Players in Central & South America (2019-2020)
12.3 Central & South America Therapeutic Plasma Exchange Market Size by Type (2015-2020)
12.4 Central & South America Therapeutic Plasma Exchange Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Asahi Kasei Corporation
13.1.1 Asahi Kasei Corporation Company Details
13.1.2 Asahi Kasei Corporation Business Overview
13.1.3 Asahi Kasei Corporation Therapeutic Plasma Exchange Introduction
13.1.4 Asahi Kasei Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020))
13.1.5 Asahi Kasei Corporation Recent Development
13.2 Baxter International
13.2.1 Baxter International Company Details
13.2.2 Baxter International Business Overview
13.2.3 Baxter International Therapeutic Plasma Exchange Introduction
13.2.4 Baxter International Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.2.5 Baxter International Recent Development
13.3 Terumo Corporation
13.3.1 Terumo Corporation Company Details
13.3.2 Terumo Corporation Business Overview
13.3.3 Terumo Corporation Therapeutic Plasma Exchange Introduction
13.3.4 Terumo Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.3.5 Terumo Corporation Recent Development
13.4 B. Braun
13.4.1 B. Braun Company Details
13.4.2 B. Braun Business Overview
13.4.3 B. Braun Therapeutic Plasma Exchange Introduction
13.4.4 B. Braun Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.4.5 B. Braun Recent Development
13.5 Fresenius Kabi
13.5.1 Fresenius Kabi Company Details
13.5.2 Fresenius Kabi Business Overview
13.5.3 Fresenius Kabi Therapeutic Plasma Exchange Introduction
13.5.4 Fresenius Kabi Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.5.5 Fresenius Kabi Recent Development
13.6 Kawasumi Laboratories
13.6.1 Kawasumi Laboratories Company Details
13.6.2 Kawasumi Laboratories Business Overview
13.6.3 Kawasumi Laboratories Therapeutic Plasma Exchange Introduction
13.6.4 Kawasumi Laboratories Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.6.5 Kawasumi Laboratories Recent Development
13.7 Haemonetics Corporation
13.7.1 Haemonetics Corporation Company Details
13.7.2 Haemonetics Corporation Business Overview
13.7.3 Haemonetics Corporation Therapeutic Plasma Exchange Introduction
13.7.4 Haemonetics Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.7.5 Haemonetics Corporation Recent Development
13.8 Cerus Corporation
13.8.1 Cerus Corporation Company Details
13.8.2 Cerus Corporation Business Overview
13.8.3 Cerus Corporation Therapeutic Plasma Exchange Introduction
13.8.4 Cerus Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.8.5 Cerus Corporation Recent Development
13.9 Hemacare Corporation
13.9.1 Hemacare Corporation Company Details
13.9.2 Hemacare Corporation Business Overview
13.9.3 Hemacare Corporation Therapeutic Plasma Exchange Introduction
13.9.4 Hemacare Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.9.5 Hemacare Corporation Recent Development
13.10 Medica S.p.A.
13.10.1 Medica S.p.A. Company Details
13.10.2 Medica S.p.A. Business Overview
13.10.3 Medica S.p.A. Therapeutic Plasma Exchange Introduction
13.10.4 Medica S.p.A. Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.10.5 Medica S.p.A. Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Asahi Kasei Corporation、Baxter International、Terumo Corporation、B. Braun、Fresenius Kabi、Kawasumi Laboratories、Haemonetics Corporation、Cerus Corporation、Hemacare Corporation、Medica S.p.A.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の治療用血漿交換市場2026:インサイト・予測(Global Therapeutic Plasma Exchange Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。